Summary of clinical results
AVENE
Clinical and instrumental effectiveness of COMEDOMED+ Intensive Care
Comparative efficacy vs. untreated
Population
36 subjects aged 18 to 34.
18 subjects per group:
- Group receiving COMEDOMED+ Intensive care 2x/day for 8 weeks
- Control group
Mild to moderate facial acne with at least 10 retention lesions and fewer than 10 inflammatory lesions.
Number of microcomedones by lesion count using the cyanoacrylate test
Results
Significant reduction in the number of retention lesions with COMEDOMED+ Intensive Care from 1 month.
Counting retention & inflammatory lesions using the lucky score method
Results
Significant reduction in the number of lesions with COMEDOMED+ Intensive Care treated vs untreated.
More summaries of clinical results
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.